Inhibition of HGF/MET signaling decreases overall tumor burden and blocks malignant conversion in Tpl2-related skin cancer

por Bonan, Nicole F., Kowalski, David, Kudlac, Kaitie, Flaherty, Kira, Gwilliam, J. Curtis, Falkenberg, Lauren G., Maradiaga, Erik, DeCicco-Skinner, Kathleen L.
Publicado 2019